BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pooladanda V, Thatikonda S, Godugu C. The current understanding and potential therapeutic options to combat COVID-19. Life Sci 2020;254:117765. [PMID: 32437797 DOI: 10.1016/j.lfs.2020.117765] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Volchenkov D. Uncertainty in Epidemic Models Based on a Three-Sided Coin. New Perspectives on Nonlinear Dynamics and Complexity 2023. [DOI: 10.1007/978-3-030-97328-5_11] [Reference Citation Analysis]
2 Al-Sehemi AG, Parulekar RS, Pannipara M, P P MA, Zubaidha PK, Bhatia MS, Mohanta TK, Al-Harrasi A. In silico evaluation of NO donor heterocyclic vasodilators as SARS-CoV-2 M(pro) protein inhibitor. J Biomol Struct Dyn 2023;41:280-97. [PMID: 34809523 DOI: 10.1080/07391102.2021.2005682] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Eslami F, Namdar R. Social, Environmental and Economic Impact Assessment of COVID-19 on Rural Tourism. Front Public Health 2022;10:883277. [PMID: 35619823 DOI: 10.3389/fpubh.2022.883277] [Reference Citation Analysis]
4 Volchenkov D. Assessing Pandemic Uncertainty on Conditions of Vaccination and Self-isolation. Lobachevskii J Math 2021;42:3550-60. [DOI: 10.1134/s1995080222020184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Miyah Y, Benjelloun M, Lairini S, Lahrichi A. COVID-19 Impact on Public Health, Environment, Human Psychology, Global Socioeconomy, and Education. ScientificWorldJournal 2022;2022:5578284. [PMID: 35069037 DOI: 10.1155/2022/5578284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
6 Charelli LE, de Mattos GC, de Jesus Sousa-Batista A, Pinto JC, Balbino TA. Polymeric nanoparticles as therapeutic agents against coronavirus disease. J Nanopart Res 2022;24:12. [PMID: 35035277 DOI: 10.1007/s11051-022-05396-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
7 Jukič M, Kores K, Janežič D, Bren U. Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints. Front Chem 2021;9:757826. [PMID: 35028304 DOI: 10.3389/fchem.2021.757826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Black SD. Molecular Modeling and Preliminary Clinical Data Suggesting Antiviral Activity for Chlorpheniramine (Chlorphenamine) Against COVID-19. Cureus 2022. [DOI: 10.7759/cureus.20980] [Reference Citation Analysis]
9 Mukherjee P, Mohapatra M. Material Aspects for Detection and Monitoring. Materials Horizons: From Nature to Nanomaterials 2022. [DOI: 10.1007/978-981-16-4372-9_6] [Reference Citation Analysis]
10 Volchenkov D. A Pandemic Three-Sided Coin. Nonlinear Systems and Complexity 2022. [DOI: 10.1007/978-3-031-06632-0_14] [Reference Citation Analysis]
11 Manik M, Singh RK. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Virol 2021. [PMID: 34672376 DOI: 10.1002/jmv.27405] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
12 Isaac-Lam MF. Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex. In Silico Pharmacol 2021;9:55. [PMID: 34631362 DOI: 10.1007/s40203-021-00114-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Swayamsiddha S, Prashant K, Shaw D, Mohanty C. The prospective of Artificial Intelligence in COVID-19 Pandemic. Health Technol (Berl) 2021;:1-10. [PMID: 34603925 DOI: 10.1007/s12553-021-00601-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Elmorsy MA, El-Baz AM, Mohamed NH, Almeer R, Abdel-Daim MM, Yahya G. In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs. Environ Sci Pollut Res Int 2021. [PMID: 34562220 DOI: 10.1007/s11356-021-16427-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Park A, Harris LK. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs. Front Immunol 2021;12:694355. [PMID: 34367154 DOI: 10.3389/fimmu.2021.694355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sayad B, Khodarahmi R, Najafi F, Miladi R, Mohseni Afshar Z, Mansouri F, Rahimi Z, Shirvani M, Salimi M, Vaziri S, Janbakhsh A, Khosravi Shadmani F, Bozorgomid A, Zamanian MH, Afsharian M. Efficacy and safety of sofosbuvir/velpatasvir versus the standard of care in adults hospitalized with COVID-19: a single-centre, randomized controlled trial. J Antimicrob Chemother 2021;76:2158-67. [PMID: 34037760 DOI: 10.1093/jac/dkab152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
17 Montes-Grajales D, Olivero-Verbel J. Bioinformatics Prediction of SARS-CoV-2 Epitopes as Vaccine Candidates for the Colombian Population. Vaccines (Basel) 2021;9:797. [PMID: 34358213 DOI: 10.3390/vaccines9070797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 E K, B.t. S, P.n. D, R. G. AN OVERVIEW ON ROLE OF ETHNOMEDICINE IN BOOSTING HUMAN IMMUNITY TO COMBAT VARIOUS VIRAL DISEASES. IAMJ 2021;9:1425-1432. [DOI: 10.46607/iamj1609072021] [Reference Citation Analysis]
19 Vartak R, Patil SM, Saraswat A, Patki M, Kunda NK, Patel K. Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro. Nanomedicine (Lond) 2021;16:1187-202. [PMID: 33982600 DOI: 10.2217/nnm-2020-0475] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
20 Shaldam MA, Yahya G, Mohamed NH, Abdel-Daim MM, Al Naggar Y. In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes. Environ Sci Pollut Res Int 2021;28:40507-14. [PMID: 33934306 DOI: 10.1007/s11356-021-14195-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
21 Greenwall L, Cebula M, Greenwall Cohen J, Effenberger S. COVID-19 testing in a UK dental practice - results of a pilot study. Br Dent J 2021. [PMID: 33883703 DOI: 10.1038/s41415-021-2849-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kim H, Lee HS, Ahn JH, Hong KS, Jang JG, An J, Mun YH, Yoo SY, Choi YJ, Yun MY, Song GY, Joo J, Na DH, Kim HN, Park HH, Lee JY, Lee W. Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm. Nano Today 2021;38:101149. [PMID: 33846686 DOI: 10.1016/j.nantod.2021.101149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
23 Barreira DF, Lourenço RA, Calisto R, Moreira-Gonçalves D, Santos LL, Videira PA. Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:660688. [PMID: 33889590 DOI: 10.3389/fmed.2021.660688] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
24 Ikonne EU, Ikpeazu VO, Ugbogu OC, Emmanuel O, Nwakuche IP, Iweala EJ, Ugbogu EA. A review on the clinical trials of repurposing therapeutic drugs, mechanisms and preventive measures against SARS-CoV-2. Drug Metab Pers Ther 2021. [PMID: 33818026 DOI: 10.1515/dmpt-2020-0184] [Reference Citation Analysis]
25 Pooladanda V, Thatikonda S, Muvvala SP, Devabattula G, Godugu C. BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome. Int J Pharm 2021;601:120536. [PMID: 33781885 DOI: 10.1016/j.ijpharm.2021.120536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
26 Si R, Lu Q, Aziz N. Impact of COVID-19 on peoples' willingness to consume wild animals: Empirical insights from China. One Health 2021;12:100240. [PMID: 33898724 DOI: 10.1016/j.onehlt.2021.100240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
27 Lu J, Guo Z, Che S, Gao F, Gu Z, Xu J, Chi Y, Xu W, Zhang J, Takuya N, Yu J, Zhao L. Dihydroartemisinin loaded layered double hydroxide nanocomposites for tumor specific photothermal-chemodynamic therapy. J Mater Chem B 2020;8:11082-9. [PMID: 33206112 DOI: 10.1039/d0tb01964j] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
28 Adeleye OA, Femi-Oyewo MN, Bamiro OA, Bakre LG, Alabi A, Ashidi JS, Balogun-Agbaje OA, Hassan OM, Fakoya G. Ethnomedicinal herbs in African traditional medicine with potential activity for the prevention, treatment, and management of coronavirus disease 2019. Futur J Pharm Sci 2021;7:72. [PMID: 33778086 DOI: 10.1186/s43094-021-00223-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
29 Attia YA, El-Saadony MT, Swelum AA, Qattan SYA, Al-Qurashi AD, Asiry KA, Shafi ME, Elbestawy AR, Gado AR, Khafaga AF, Hussein EOS, Ba-Awadh H, Tiwari R, Dhama K, Alhussaini B, Alyileili SR, El-Tarabily KA, Abd El-Hack ME. COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an updated review. Environ Sci Pollut Res Int 2021;28:22241-64. [PMID: 33733422 DOI: 10.1007/s11356-021-13018-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
30 Brownstein NC, Chen YA. Predictive values, uncertainty, and interpretation of serology tests for the novel coronavirus. Sci Rep 2021;11:5491. [PMID: 33750810 DOI: 10.1038/s41598-021-84173-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
31 Almarzooq AA. Exploration of interethnic variation and repurposed drug efficacy in the treatment of SARS-CoV-2 Infection (COVID-19).. [DOI: 10.1101/2021.03.07.21253095] [Reference Citation Analysis]
32 Karkischenko VN, Petrova NV, Savchenko ES, Ogneva NS, Koloskova EM, Maksimenko SV, Manuvera VA, Bobrovsky PA, Lazarev VN. Chimeric Construct Engineering with Human Variant HLA-A<sup>*</sup>02:01:01:01. BIOMEDICINE 2021;17:10-23. [DOI: 10.33647/2074-5982-17-1-10-23] [Reference Citation Analysis]
33 Shahcheraghi SH, Ayatollahi J, Aljabali AA, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Katari NK, Mehta M, Satija S, Dureja H, Mishra V, Almutary AG, Alnuqaydan AM, Charbe N, Prasher P, Gupta G, Dua K, Lotfi M, Bakshi HA, Tambuwala MM. An overview of vaccine development for COVID-19. Ther Deliv 2021;12:235-44. [PMID: 33624533 DOI: 10.4155/tde-2020-0129] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
34 El-Sayed A, Aleya L, Kamel M. COVID-19: a new emerging respiratory disease from the neurological perspective. Environ Sci Pollut Res Int 2021;28:40445-59. [PMID: 33590398 DOI: 10.1007/s11356-021-12969-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
35 Umakanthan S, Chattu VK, Ranade AV, Das D, Basavarajegowda A, Bukelo M. A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19. AIMS Public Health 2021;8:137-53. [PMID: 33575413 DOI: 10.3934/publichealth.2021011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
36 Ravi S, Jadhav S, Vaidya A, Ghooi R. Repurposing drugs during the COVID-19 pandemic and beyond. Pharm Pat Anal 2021;10:9-12. [PMID: 33445955 DOI: 10.4155/ppa-2020-0031] [Reference Citation Analysis]
37 Pooladanda V, Thatikonda S, Sunnapu O, Tiwary S, Vemula PK, Talluri MVNK, Godugu C. iRGD conjugated nimbolide liposomes protect against endotoxin induced acute respiratory distress syndrome. Nanomedicine 2021;33:102351. [PMID: 33418136 DOI: 10.1016/j.nano.2020.102351] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
38 Subash S, Pandit S, H G N. The Current Understanding and Potential Therapeutic Options to Combat COVID-19. SSRN Journal. [DOI: 10.2139/ssrn.3759166] [Reference Citation Analysis]
39 Li D, Hu J, Li D, Yang W, Yin SF, Qiu R. Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19. Top Curr Chem (Cham) 2021;379:4. [PMID: 33428032 DOI: 10.1007/s41061-020-00318-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
40 Bellera CL, Llanos M, Gantner ME, Rodriguez S, Gavernet L, Comini M, Talevi A. Can drug repurposing strategies be the solution to the COVID-19 crisis? Expert Opin Drug Discov 2021;16:605-12. [PMID: 33345645 DOI: 10.1080/17460441.2021.1863943] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
41 Brownstein NC, Chen YA. Predictive values, uncertainty, and interpretation of serology tests for the novel coronavirus. medRxiv 2020:2020. [PMID: 32577683 DOI: 10.1101/2020.06.04.20122358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Mulaw Belete T. An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease. Clin Pharmacol 2020;12:203-12. [PMID: 33363416 DOI: 10.2147/CPAA.S284809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
43 Al-Mandhari AS, Brennan RJ, Abubakar A, Hajjeh R. Tackling COVID-19 in the Eastern Mediterranean Region. Lancet 2020;396:1786-8. [PMID: 33220856 DOI: 10.1016/S0140-6736(20)32349-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
44 Park A, Harris LK. Gene Expression Meta-Analysis Reveals Interferon-induced Genes.. [DOI: 10.1101/2020.11.14.382697] [Reference Citation Analysis]
45 Adhikari N, Amin SA, Jha T. Dissecting the Drug Development Strategies Against SARS-CoV-2 Through Diverse Computational Modeling Techniques. New York: Springer US; 2020. [DOI: 10.1007/7653_2020_46] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Papageorgiou AC, Mohsin I. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies. Cells 2020;9:E2343. [PMID: 33105869 DOI: 10.3390/cells9112343] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 15.3] [Reference Citation Analysis]
47 Babich O, Sukhikh S, Prosekov A, Asyakina L, Ivanova S. Medicinal Plants to Strengthen Immunity during a Pandemic. Pharmaceuticals (Basel) 2020;13:E313. [PMID: 33076514 DOI: 10.3390/ph13100313] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
48 Asif M. Coronavirus (COVID-19) Symptoms, Treatment, and Recent Medical Challenges to the World: A Review. KJDMR 2020;4:23-31. [DOI: 10.47705/kjdmr.204204] [Reference Citation Analysis]
49 Guan J, Wei X, Qin S, Liu X, Jiang Y, Chen Y, Chen Y, Lu H, Qian J, Wang Z, Lin X. Continuous tracking of COVID-19 patients' immune status. Int Immunopharmacol 2020;89:107034. [PMID: 33039966 DOI: 10.1016/j.intimp.2020.107034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
50 Zubiaur P, Koller D, Saiz-Rodríguez M, Navares-Gómez M, Abad-Santos F. Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Clin Transl Sci 2020;13:1023-33. [PMID: 32936528 DOI: 10.1111/cts.12866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
51 Panossian A, Brendler T. The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections. Pharmaceuticals (Basel) 2020;13:E236. [PMID: 32911682 DOI: 10.3390/ph13090236] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
52 Yousefinejad V, Moradi B, Mohammadi Baneh A, Sheikhesmaeili F, Babahajian A. Prognostic Factors of Outcome in Methanol Poisoning; an 8-year Retrospective Cross-sectional Study. Arch Acad Emerg Med 2020;8:e69. [PMID: 33134965] [Reference Citation Analysis]
53 Bhavana V, Thakor P, Singh SB, Mehra NK. COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic. Life Sci 2020;261:118336. [PMID: 32846164 DOI: 10.1016/j.lfs.2020.118336] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
54 Mainardes RM, Diedrich C. The potential role of nanomedicine on COVID-19 therapeutics. Ther Deliv 2020;11:411-4. [PMID: 32594863 DOI: 10.4155/tde-2020-0069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
55 Tarasova O, Ivanov S, Filimonov DA, Poroikov V. Data and Text Mining Help Identify Key Proteins Involved in the Molecular Mechanisms Shared by SARS-CoV-2 and HIV-1. Molecules 2020;25:E2944. [PMID: 32604797 DOI: 10.3390/molecules25122944] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]